Amorolfine

{{Drugbox | Watchedfields = changed | verifiedrevid = 443386467 | IUPAC_name = (±)-(2R*,6S*)-2,6-dimethyl-4-{2-methyl-3-[4-(2-methylbutan-2-yl)phenyl]propyl}morpholine | image =Amorolfine.png

| tradename = | Drugs.com = International Drug Names | pregnancy_AU = | pregnancy_US = | pregnancy_category = | legal_AU = | legal_CA = | legal_UK = | legal_US = | legal_status = | routes_of_administration =

| bioavailability = | protein_bound = | metabolism = | elimination_half-life = | excretion =

| CAS_number_Ref =  ^Y | CAS_number = 78613-35-1 | ATC_prefix = D01 | ATC_suffix = AE16 | PubChem = 54260 | DrugBank_Ref =  ^Y | DrugBank = | ChemSpiderID_Ref =  ^Y | ChemSpiderID = 49010 | UNII_Ref =  ^Y | UNII = AB0BHP2FH0 | KEGG_Ref =  ^Y | KEGG = D02923 | ChEBI_Ref =  ^Y | ChEBI = 599440 | ChEMBL_Ref =  ^Y | ChEMBL = 489411

| C=21 | H=35 | N=1 | O=1 | molecular_weight = 317.509 g/mol | smiles = O2[C@@H](CN(CC(C)Cc1ccc(cc1)C(C)(C)CC)C[C@@H]2C)C | InChI = 1/C21H35NO/c1-7-21(5,6)20-10-8-19(9-11-20)12-16(2)13-22-14-17(3)23-18(4)15-22/h8-11,16-18H,7,12-15H2,1-6H3/t16?,17-,18+ | InChIKey = MQHLMHIZUIDKOO-AYHJJNSGBZ | StdInChI_Ref =  ^Y | StdInChI = 1S/C21H35NO/c1-7-21(5,6)20-10-8-19(9-11-20)12-16(2)13-22-14-17(3)23-18(4)15-22/h8-11,16-18H,7,12-15H2,1-6H3/t16?,17-,18+ | StdInChIKey_Ref =  ^Y | StdInChIKey = MQHLMHIZUIDKOO-AYHJJNSGSA-N }}

WikiDoc Resources for Amorolfine
Articles
Most recent articles on Amorolfine Most cited articles on Amorolfine Review articles on Amorolfine Articles on Amorolfine in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Amorolfine Images of Amorolfine Photos of Amorolfine Podcasts & MP3s on Amorolfine Videos on Amorolfine
Evidence Based Medicine
Cochrane Collaboration on Amorolfine Bandolier on Amorolfine TRIP on Amorolfine
Clinical Trials
Ongoing Trials on Amorolfine at Clinical Trials.gov Trial results on Amorolfine Clinical Trials on Amorolfine at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Amorolfine NICE Guidance on Amorolfine NHS PRODIGY Guidance FDA on Amorolfine CDC on Amorolfine
Books
Books on Amorolfine
News
Amorolfine in the news Be alerted to news on Amorolfine News trends on Amorolfine
Commentary
Blogs on Amorolfine
Definitions
Definitions of Amorolfine
Patient Resources / Community
Patient resources on Amorolfine Discussion groups on Amorolfine Patient Handouts on Amorolfine Directions to Hospitals Treating Amorolfine Risk calculators and risk factors for Amorolfine
Healthcare Provider Resources
Symptoms of Amorolfine Causes & Risk Factors for Amorolfine Diagnostic studies for Amorolfine Treatment of Amorolfine
Continuing Medical Education (CME)
CME Programs on Amorolfine
International
Amorolfine en Espanol Amorolfine en Francais
Business
Amorolfine in the Marketplace Patents on Amorolfine
Experimental / Informatics
List of terms related to Amorolfine

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Amorolfine (or amorolfin), is a morpholine antifungal drug that inhibits D14 reductase and D7-D8 isomerase, which depletes ergosterol and causes ignosterol to accumulate in the fungal cytoplasmic cell membranes. Marketed as Curanail, Loceryl, Locetar, and Odenil, amorolfine is commonly available in the form of a nail lacquer, containing 5% amorolfine as the active ingredient. It is used to treat onychomycosis (fungal infection of the toe- and fingernails). Amorolfine 5% nail lacquer in once-weekly or twice-weekly applications has been shown in two studies to be between 60% and 71% effective in treating toenail onychomycosis; complete cure rates three months after stopping treatment (after six months of treatment) were 38% and 46%. However, full experimental details of these trials were not available and since they were first reported in 1992 there have been no subsequent trials.

It is a topical solution for the treatment of toenail infections. Systemic treatments may be considered more effective.

It is approved for sale over the counter in Australia and the UK (recently re-classified to over the counter status), and is approved for the treatment of toenail fungus by prescription in other countries. It is not approved for the treatment of onychomycosis in the United States or Canada, but can be ordered from there by mail from other countries.